131 related articles for article (PubMed ID: 8661397)
21. Properties of HIV membrane reconstituted from its recombinant gp160 envelope glycoprotein.
Cornet B; Decroly E; Thines-Sempoux D; Ruysschaert JM; Vandenbranden M
AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1823-31. PubMed ID: 1457195
[TBL] [Abstract][Full Text] [Related]
22. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
Welman M; Lemay G; Cohen EA
Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
[TBL] [Abstract][Full Text] [Related]
23. Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage.
Guo HG; Veronese FM; Tschachler E; Pal R; Kalyanaraman VS; Gallo RC; Reitz MS
Virology; 1990 Jan; 174(1):217-24. PubMed ID: 2104682
[TBL] [Abstract][Full Text] [Related]
24. Human immunodeficiency virus type 1 glycoprotein precursor retains a CD4-p56lck complex in the endoplasmic reticulum.
Crise B; Rose JK
J Virol; 1992 Apr; 66(4):2296-301. PubMed ID: 1548763
[TBL] [Abstract][Full Text] [Related]
25. Impairment of T cell receptor-dependent stimulation in CD4+ lymphocytes after contact with membrane-bound HIV-1 envelope glycoprotein.
Schwartz O; Alizon M; Heard JM; Danos O
Virology; 1994 Jan; 198(1):360-5. PubMed ID: 7903129
[TBL] [Abstract][Full Text] [Related]
26. Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor.
Weissman D; Rabin RL; Arthos J; Rubbert A; Dybul M; Swofford R; Venkatesan S; Farber JM; Fauci AS
Nature; 1997 Oct; 389(6654):981-5. PubMed ID: 9353123
[TBL] [Abstract][Full Text] [Related]
27. Mutational analysis of the HIV-1 Vpu protein.
Friborg J; Yao XJ; Boisvert F; Garzon S; Cohen EA
Leukemia; 1994 Apr; 8 Suppl 1():S156-62. PubMed ID: 8152284
[TBL] [Abstract][Full Text] [Related]
28. Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum.
Vincent MJ; Raja NU; Jabbar MA
J Virol; 1993 Sep; 67(9):5538-49. PubMed ID: 8350411
[TBL] [Abstract][Full Text] [Related]
29. CD4 is retained in the endoplasmic reticulum by the human immunodeficiency virus type 1 glycoprotein precursor.
Crise B; Buonocore L; Rose JK
J Virol; 1990 Nov; 64(11):5585-93. PubMed ID: 2214026
[TBL] [Abstract][Full Text] [Related]
30. Glycans and proteoglycans are involved in the interactions of human immunodeficiency virus type 1 envelope glycoprotein and of SDF-1alpha with membrane ligands of CD4(+) CXCR4(+) cells.
Mbemba E; Benjouad A; Saffar L; Gattegno L
Virology; 1999 Dec; 265(2):354-64. PubMed ID: 10600606
[TBL] [Abstract][Full Text] [Related]
31. Identification of membrane anchorage domains of the HIV-1 gp160 envelope glycoprotein precursor.
Gabuzda D; Olshevsky U; Bertani P; Haseltine WA; Sodroski J
J Acquir Immune Defic Syndr (1988); 1991; 4(1):34-40. PubMed ID: 1984054
[TBL] [Abstract][Full Text] [Related]
32. HIV-gp 160-induced T cell-dependent B cell differentiation. Role of T cell-B cell activation molecule and IL-6.
Chirmule N; Kalyanaraman VS; Lederman S; Oyaizu N; Yagura H; Yellin MJ; Chess L; Pahwa S
J Immunol; 1993 Mar; 150(6):2478-86. PubMed ID: 8450224
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1.
Kalyanaraman VS; Rodriguez V; Veronese F; Rahman R; Lusso P; DeVico AL; Copeland T; Oroszlan S; Gallo RC; Sarngadharan MG
AIDS Res Hum Retroviruses; 1990 Mar; 6(3):371-80. PubMed ID: 2187500
[TBL] [Abstract][Full Text] [Related]
34. Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity.
Page KA; Stearns SM; Littman DR
J Virol; 1992 Jan; 66(1):524-33. PubMed ID: 1727497
[TBL] [Abstract][Full Text] [Related]
35. Virological importance of the protease-cleavage site in human immunodeficiency virus type 1 Nef is independent of both intravirion processing and CD4 down-regulation.
Pandori M; Craig H; Moutouh L; Corbeil J; Guatelli J
Virology; 1998 Nov; 251(2):302-16. PubMed ID: 9837795
[TBL] [Abstract][Full Text] [Related]
36. Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41.
Chen SS; Lee SF; Wang CT
J Virol; 2001 Oct; 75(20):9925-38. PubMed ID: 11559825
[TBL] [Abstract][Full Text] [Related]
37. Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes.
Willey RL; Maldarelli F; Martin MA; Strebel K
J Virol; 1992 Jan; 66(1):226-34. PubMed ID: 1727486
[TBL] [Abstract][Full Text] [Related]
38. The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion.
Ablan S; Rawat SS; Viard M; Wang JM; Puri A; Blumenthal R
Virol J; 2006 Dec; 3():104. PubMed ID: 17187670
[TBL] [Abstract][Full Text] [Related]
39. Vpu-mediated proteolysis of gp160/CD4 chimeric envelope glycoproteins in the endoplasmic reticulum: requirement of both the anchor and cytoplasmic domains of CD4.
Raja NU; Vincent MJ; abdul Jabbar M
Virology; 1994 Oct; 204(1):357-66. PubMed ID: 8091666
[TBL] [Abstract][Full Text] [Related]
40. A plasma membrane localization signal in the HIV-1 envelope cytoplasmic domain prevents localization at sites of vesicular stomatitis virus budding and incorporation into VSV virions.
Johnson JE; Rodgers W; Rose JK
Virology; 1998 Nov; 251(2):244-52. PubMed ID: 9837788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
